High Quality Stocks
IX1.DE is part of our High Quality Stocks screen, meaning it meets strict criteria for profitability, capital efficiency, and long-term growth consistency.
IDEXX LABORATORIES INC (IX1.DE) Stock Price & Overview
FRA:IX1 • US45168D1046
Current stock price
481.1 EUR
-8.8 (-1.8%)
Last:
The current stock price of IX1.DE is 481.1 EUR. Today IX1.DE is down by -1.8%. In the past month the price decreased by -5.33%. In the past year, price increased by 18.88%.
IX1.DE Key Statistics
52-Week Range375.8 - 663.2
Current IX1.DE stock price positioned within its 52-week range.
1-Month Range480 - 561.8
Current IX1.DE stock price positioned within its 1-month range.
- Market Cap
- 38.209B
- P/E
- 43.11
- Fwd P/E
- 38.05
- EPS (TTM)
- 11.16
- Dividend Yield
- N/A
IX1.DE Stock Performance
Today
-1.8%
1 Week
+2.46%
1 Month
-5.33%
3 Months
-10.53%
Longer-term
6 Months +16.35%
1 Year +18.88%
2 Years +13.92%
3 Years +2.87%
5 Years N/A
10 Years N/A
IX1.DE Stock Chart
IX1.DE Stock Screens
IX1.DE currently appears in the following ChartMill screener lists.
IX1.DE Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to IX1.DE. When comparing the yearly performance of all stocks, IX1.DE turns out to be only a medium performer in the overall market: it outperformed 44.95% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
IX1.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to IX1.DE. IX1.DE gets an excellent profitability rating and is at the same time showing great financial health properties.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
IX1.DE Earnings
On February 2, 2026 IX1.DE reported an EPS of 3.08 and a revenue of 1.09B. The company beat EPS expectations (3.12% surprise) and missed revenue expectations (-0.31% surprise).
Next Earnings DateMay 5, 2026
Last Earnings DateFeb 2, 2026
PeriodQ4 / 2025
EPS Reported$3.08
Revenue Reported1.091B
EPS Surprise 3.12%
Revenue Surprise -0.31%
IX1.DE Forecast & Estimates
22 analysts have analysed IX1.DE and the average price target is 655.41 EUR. This implies a price increase of 36.23% is expected in the next year compared to the current price of 481.1.
For the next year, analysts expect an EPS growth of 13.3% and a revenue growth 9.17% for IX1.DE
Analysts
Analysts80.91
Price Target655.41 (36.23%)
EPS Next Y13.3%
Revenue Next Year9.17%
IX1.DE Groups
Sector & Classification
IX1.DE Financial Highlights
Over the last trailing twelve months IX1.DE reported a non-GAAP Earnings per Share(EPS) of 11.16. The EPS increased by 16.18% compared to the year before.
Income Statements
Revenue(TTM)4.30B
Net Income(TTM)1.06B
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 24.62% | ||
| ROA | 31.62% | ||
| ROE | 65.99% | ||
| Debt/Equity | 0.48 |
Chartmill High Growth Momentum
EPS Q2Q%17.56%
Sales Q2Q%14.28%
EPS 1Y (TTM)16.18%
Revenue 1Y (TTM)10.42%
IX1.DE Ownership
Ownership
Inst Owners95.6%
Shares79.42M
Float78.85M
Ins Owners0.21%
Short Float %N/A
Short RatioN/A
IX1.DE Competitors/Peers
The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 2M6 | MEDTRONIC PLC | 14.11 | 95.649B | ||
| SHL | SIEMENS HEALTHINEERS AG | 14.27 | 42.605B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 15.91 | 23.37B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 15.88 | 23.361B | ||
| 1PHIA | KONINKLIJKE PHILIPS NV | 15.63 | 23.014B | ||
| BIM | BIOMERIEUX | 18.67 | 10.676B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 18.6 | 3.519B | ||
| DIA | DIASORIN SPA | 15.13 | 3.419B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 14.02 | 2.32B | ||
| 1AFX | CARL ZEISS MEDITEC AG - BR | 12.37 | 2.274B | ||
| DRW3 | DRAEGERWERK AG - PREF | 11.68 | 1.773B | ||
| DRW8 | DRAEGERWERK AG | 9.23 | 1.407B | ||
| ELN | EL.EN. SPA | 17.04 | 1.051B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About IX1.DE
Company Profile
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.
Company Info
IPO: 1991-06-21
IDEXX LABORATORIES INC
One Idexx Drive
Westbrook MAINE US
Employees: 11000
Phone: 12075560300
IDEXX LABORATORIES INC / IX1.DE FAQ
What does IDEXX LABORATORIES INC do?
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.
What is the current price of IX1 stock?
The current stock price of IX1.DE is 481.1 EUR. The price decreased by -1.8% in the last trading session.
Does IDEXX LABORATORIES INC pay dividends?
IX1.DE does not pay a dividend.
What is the ChartMill rating of IDEXX LABORATORIES INC stock?
IX1.DE has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
On which exchange is IX1.DE stock listed?
IX1.DE stock is listed on the Frankfurt Stock Exchange exchange.
Is IDEXX LABORATORIES INC (IX1.DE) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on IX1.DE.
Can you provide the upcoming earnings date for IDEXX LABORATORIES INC?
IDEXX LABORATORIES INC (IX1.DE) will report earnings on 2026-05-05, before the market open.